← Leaderboards
Felix Dietlein
Dana-Farber Cancer Inst
$2,438,675
Attributed
$2,438,675
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,438,675 · 3
By mechanism
DP2$1,593,000 · 1
R00$712,480 · 1
K99$133,195 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Laurie H Glimcher$56,303,115
- Jeffrey Wade Harper$36,219,392
- Timothy R Rebbeck$50,819,475
- Piotr Sicinski$42,703,610
- Bruce M Spiegelman$59,708,812
Others in their field
Other Emerging Leaders on “Structure”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,827,589
- John Damon Chodera · Sloan-Kettering Inst Can Research$62,074,236
Research focus
StructurePublic HealthInnovationSomatic MutationWhole GenomeTumorDrug TargetingGenomicsMissionSignal TransductionUnited States National Institutes Of HealthUntranslated RnaCancer Gene ExpressionCancer GenomeComplexDriver MutationEnvironmentGenomeClustered Regularly Interspaced Short Palindromic RepeatsMalignant NeoplasmsMutationAffectAtlasesBiology
Grant awards (5)
A pan-cancer atlas of driver mutations in >100,000 patients based on a hypothesis-driven combined computational and experimental approach$249,000
R00 · FY2024 · CA · contact PI
Defining the universal genomic language of hallmarks in tumor development$1,593,000
DP2 · FY2023 · CA · contact PI
A pan-cancer atlas of driver mutations in >100,000 patients based on a hypothesis-driven combined computational and experimental approach$214,480
R00 · FY2023 · CA · contact PI
A pan-cancer atlas of driver mutations in >100,000 patients based on a hypothesis-driven combined computational and experimental approach$249,000
R00 · FY2022 · CA · contact PI
A pan-cancer atlas of driver mutations in >100,000 patients based on a hypothesis-driven combined computational and experimental approach$133,195
K99 · FY2021 · CA · contact PI